Detalle Publicación

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

Autores: Buske, C. (Autor de correspondencia); Dreyling, M.; Álvarez-Larrán, A.; Apperley, J.; Arcaini, L.; Besson, C.; Bullinger, L.; Corradini, P.; Della Porta, M. G.; Dimopoulos, M.; D'Sa, S.; Eich, H. T.; Foa, R.; Ghia, P.; da Silva, M. G.; Gribben, J.; Hajek, R.; Harrison, C.; Heuser, M.; Kiesewetter, B.; Kiladjian, J. J.; Kroeger, N.; Moreau, P.; Passweg, J. R.; Peyvandi, F.; Rea, D.; Ribera, J. M.; Robak, T.; San Miguel Izquierdo, Jesús; Santini, V.; Sanz, G.; Sonneveld, P.; Von Lilienfeld-Toal, M.; Wendtner, C.; Pentheroudakis, G.; Passamonti, F. (Autor de correspondencia)
Título de la revista: ESMO OPEN
ISSN: 2059-7029
Volumen: 7
Número: 2
Páginas: 100403
Fecha de publicación: 2022
Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. Methods: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. Results and conclusion: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.